MHRA updates guidance on the supply of medicines to NI
The Medicines and Healthcare products Regulatory Agency (MHRA) has updated its guidance on the supply of medicines to Northern Ireland … read more »
ABPI responds to PM’s Brexit comments
The ABPI has responded to the Prime Minister’s comments on the possibility of a ‘no deal’ Brexit. The Prime … read more »
UK orphan medicine designation to be implemented
The UK has designed an independent replacement for present system for officially designating a medicine as ‘orphan’, i.e. for rare … read more »
Guidance issued for post-Transition Period supply of medicines to NI
As the end of the Transition Period nears, the Department of Health and Social Care (DHSC) has issued advice on … read more »
UK and EU pharmaceutical industry jointly urges protection of medicines before Brexit transition period ends
As the deadline for Brexit negotiations approaches, the UK and EU pharmaceutical industry trade bodies, the Association of the British … read more »
Royal Pharmaceutical Society calls for law change to combat shortages
The Royal Pharmaceutical Society (RPS) has combined with the British Medical Association (BMA), the Royal College of GPs (RCGP) and … read more »
ABPI responds to UK-Japan trade agreement
The Association of the British Pharmaceutical Industry (ABPI) has commented on the new deal between the UK and Japan, as … read more »
MHRA launches Brexit guidance
The Medicines and Healthcare Products Regulatory Agency (MHRA) has released a raft of documents, with more to follow, explaining the … read more »
Government publishes guidance on moving goods under the Northern Ireland Protocol
The Government has published guidance for businesses on moving goods to and from Northern Ireland under the Northern Ireland Protocol … read more »
DHSC sends Brexit notice to companies
The Department of Health and Social Care (DHSC) has sent a letter to medicines and medical device companies to give … read more »
